Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering new RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD). Wave claims this is the first clinical ...
The Federal Reserve has already lowered rates twice in 2025, but with just one meeting left before the new year, consumers are eager to learn if there will be another cut. Following a series of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback